Modified Erasmus GBS Outcome Score (EGOS) at hospital admission
Predict probability of being unable to walk independently during follow up in patients with Guillain-Barré syndrome. Score taken at hospital admission.
About
The mEGOS is a clinical prediction model that can be applied early in the course of disease to predict the probability of being unable to walk independently during the first six months of follow up, in individual patients with Guillain-Barré syndrome.
The score is developed and validated using prospectively collected data from a Dutch GBS cohort, and recently showed good performance in a GBS cohort from Japan.
Age at onset of neurological symptoms, preceding diarrhoea and severity of muscle weakness (at hospital admission, and at day 7 of admission) defined by the MRC sum score were independently associated with the ability to walk independently during the first six months of follow up. Two logistic regression models were generated based on these risk factors:
- 1. A model based on assessment at hospital admission to estimate the probability of being unable to walk independently during the first six months of follow up.
- 2. A model based on assessment at day 7 of admission to estimate the probability of being unable to walk independently during the first six months of follow up.
References
Walgaard C, Lingsma HF, Ruts L, van Doorn PA, Steyerberg EW, Jacobs BC.
Yamagishi Y, Suzuki H, et al.
By using this site you acknowledge that you have read, understand, and agree to be bound by our terms of use and privacy policy. All content and tools are for educational use only, are not meant to be a substitute for professional advice and should not be used for medical diagnosis and/or medical treatment.